Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-15 Option Award | 2023-06-20 4:06 pm | N/A 2033-06-14 | Avidity Biosciences Inc. | RNA | Mosbrooker Eric Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 8:58 pm | N/A 2032-06-14 | Avidity Biosciences Inc. | RNA | Mosbrooker Eric Director | 22,000 | $0 | 22,000 (Direct) | View |
| 2021-08-25 Option Award | 2021-08-27 7:37 pm | N/A 2031-08-24 | Avidity Biosciences Inc. | RNA | Mosbrooker Eric Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2020-01-15 Equity Swap | 2020-01-15 1:34 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Mosbrooker Eric SVP, Chief Commercial Officer | 26,919 | $60 | 0 (Direct) | View |
| 2020-01-15 Disposition | 2020-01-15 1:34 pm | N/A 2029-01-03 | Audentes Therapeutics Inc. | BOLD | Mosbrooker Eric SVP, Chief Commercial Officer | 87,750 | $0 | 0 (Direct) | View |
| 2019-12-12 Tax Withholding | 2019-12-16 6:04 pm | N/A N/A | Audentes Therapeutics Inc. | BOLD | Mosbrooker Eric SVP, Chief Commercial Officer | 4,881 | $59.37 | 26,919 (Direct) | View |